BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17725409)

  • 1. Treating the genetic make-up of breast cancer: a new fashion?
    Linn SC; Jonkers J
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1065-7. PubMed ID: 17725409
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side.
    Garber JE; Golshan M
    J Clin Oncol; 2009 Dec; 27(35):5862-4. PubMed ID: 19858367
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on screening breast MRI in high-risk women.
    Boetes C
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):149-58, viii-ix. PubMed ID: 21419331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of BRCA1, BRCA2 and RAD51 as biomarkers for breast cancer.
    Ziogas D; Liakakos T; Lykoudis E; Fatourou E; Roukos DH
    Radiother Oncol; 2009 Jan; 90(1):161-2. PubMed ID: 18343512
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice. Management of an inherited predisposition to breast cancer.
    Robson M; Offit K
    N Engl J Med; 2007 Jul; 357(2):154-62. PubMed ID: 17625127
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic testing in patients at risk for carcinoma of the breast].
    Kiechle M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2420-2. PubMed ID: 17054060
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
    Feig S
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA screening.
    Med Lett Drugs Ther; 2007 Nov; 49(1274):93-4. PubMed ID: 18007543
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast magnetic resonance imaging for screening high-risk women.
    Sung JS; Dershaw DD
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):509-17. PubMed ID: 23928241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic changes in breast cancer - an overview].
    Dimitrov G; Iovchev I; Nikolov S
    Khirurgiia (Sofiia); 2000; 56(5-6):60-2. PubMed ID: 11692938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1/2-associated and sporadic breast cancers: fellow travelers or not?
    Garber JE
    Cancer Prev Res (Phila); 2009 Feb; 2(2):100-3. PubMed ID: 19174575
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer risk assessment at the atomic level.
    Monteiro AN; Couch FJ
    Cancer Res; 2006 Feb; 66(4):1897-9. PubMed ID: 16488985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current aspects of breast carcinoma: 2].
    Petru E
    Wien Med Wochenschr; 2010 Nov; 160(19-20):477. PubMed ID: 20972710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Present conditions and the prospects for biomarker measurement in breast cancer].
    Kawamoto H; Fukuda M
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():281-4. PubMed ID: 17679203
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation.
    del Valle J; Feliubadaló L; Lázaro C
    Breast Cancer Res Treat; 2010 Nov; 124(1):295-6. PubMed ID: 20706784
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond BRCA1/2: polygenic, 'polyfunctional' molecular circuitry model to predict breast cancer risk.
    Lianos GD; Zoras O; Roukos DH
    Biomark Med; 2013 Oct; 7(5):675-8. PubMed ID: 24044557
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI in breast cancer management: potential for benefit and harm.
    Jatoi I
    Int J Fertil Womens Med; 2005; 50(6):281-4. PubMed ID: 16526420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Foulkes WD; Kim-Sing C; Ainsworth P; Rosen B; Armel S; Poll A; Eisen A; Gilchrist D; Chudley A; Ghadirian P; Maugard C; Lemire EG; Sun P; Narod SA
    Clin Genet; 2008 May; 73(5):474-9. PubMed ID: 18341607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.